(Q54368670)

English

Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.

scientific article published in January 1989

In more languages
default for all languages
No label defined

No description defined

Statements

Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit